Prognostic Characteristics of MACC1 Expression in Epithelial Ovarian Cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jeong, Hoiseon | - |
dc.contributor.author | Jung, Jiyoon | - |
dc.contributor.author | Oh, Hwa Eun | - |
dc.contributor.author | Choi, Jung-Woo | - |
dc.contributor.author | Lee, Eung Seok | - |
dc.contributor.author | Kim, Young-Sik | - |
dc.contributor.author | Lee, Ju-Han | - |
dc.date.accessioned | 2021-12-19T05:41:14Z | - |
dc.date.available | 2021-12-19T05:41:14Z | - |
dc.date.created | 2021-08-30 | - |
dc.date.issued | 2018 | - |
dc.identifier.issn | 2314-6133 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/132139 | - |
dc.description.abstract | Recent studies have shown that overexpression of metastasis-associated in colon cancer 1 (MACC1) is significantly associated with adverse prognoses of patients with different kinds of cancer. However, the exact survival effect of mAca on epithelial ovarian cancer (EOC) patients has not yet been established. Thus, the objective of this study was to explore the prognostic role of MACC1 mRNA in EOC by using Kaplan-Meier (KM) plotter and ONCOMINE database. Our results indicated that MACC1 mRNA high expression was significantly associated with unfavorable overall survival (hazard ratio (HR) = 1.51 (95% confidence interval (CI): 1.21 - 1.88), P = 0.00025) and progression-free survival (HR = 1.53 (95% CI: 1.24 - 1.89), P = 5.8e-05) in EOC patients. We also found that the expression of MACC1 mRNA in EOC was 2.5 tones higher than that in normal surface ovarian epithelium, which was statistically significant (P = 2.86e-7). Our results suggest that MACC1 expression might be a biomarker for poor prognosis in individual EOC patients. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | HINDAWI LTD | - |
dc.subject | POOR-PROGNOSIS | - |
dc.subject | GENE | - |
dc.subject | OVEREXPRESSION | - |
dc.subject | METASTASIS | - |
dc.subject | SURVIVAL | - |
dc.subject | CHEMOTHERAPY | - |
dc.subject | CARCINOMA | - |
dc.subject | PREDICTS | - |
dc.subject | MARKER | - |
dc.title | Prognostic Characteristics of MACC1 Expression in Epithelial Ovarian Cancer | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Jung-Woo | - |
dc.contributor.affiliatedAuthor | Lee, Eung Seok | - |
dc.contributor.affiliatedAuthor | Kim, Young-Sik | - |
dc.contributor.affiliatedAuthor | Lee, Ju-Han | - |
dc.identifier.doi | 10.1155/2018/9207153 | - |
dc.identifier.scopusid | 2-s2.0-85062824514 | - |
dc.identifier.wosid | 000449783300001 | - |
dc.identifier.bibliographicCitation | BIOMED RESEARCH INTERNATIONAL, v.2018 | - |
dc.relation.isPartOf | BIOMED RESEARCH INTERNATIONAL | - |
dc.citation.title | BIOMED RESEARCH INTERNATIONAL | - |
dc.citation.volume | 2018 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.subject.keywordPlus | POOR-PROGNOSIS | - |
dc.subject.keywordPlus | GENE | - |
dc.subject.keywordPlus | OVEREXPRESSION | - |
dc.subject.keywordPlus | METASTASIS | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | CHEMOTHERAPY | - |
dc.subject.keywordPlus | CARCINOMA | - |
dc.subject.keywordPlus | PREDICTS | - |
dc.subject.keywordPlus | MARKER | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.